These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 6751163)

  • 1. Autoantibodies in thromboangiitis obliterans (Buerger's disease).
    Gulati SM; Madhra K; Thusoo TK; Nair SK; Saha K
    Angiology; 1982 Oct; 33(10):642-51. PubMed ID: 6751163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New aspects of thromboangiitis obliterans (von Winiwarter-Buerger's disease).
    Berlit P; Kessler C; Reuther R; Krause KH
    Eur Neurol; 1984; 23(6):394-9. PubMed ID: 6391927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profile of non-organ specific autoantibodies in thromboangiitis obliterans.
    Gulati SM; Saha K; Agarwal V; Thusoo TK; Mehdiratta KS
    Indian J Med Res; 1984 Aug; 80():228-31. PubMed ID: 6334652
    [No Abstract]   [Full Text] [Related]  

  • 4. Study of anti-neutrophil cytoplasmic antibodies in patients with thromboangiitis obliterans (Buerger's disease).
    Halacheva KS; Manolova IM; Petkov DP; Andreev AP
    Scand J Immunol; 1998 Nov; 48(5):544-50. PubMed ID: 9822265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmunological aspects of thromboangiitis obliterans (Buerger's disease).
    Smolen JS; Youngchaiyud U; Weidinger P; Kojer M; Endler AT; Mayr WR; Menzel EJ
    Clin Immunol Immunopathol; 1978 Oct; 11(2):168-77. PubMed ID: 367656
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiendothelial cell antibodies in thromboangiitis obliterans.
    Eichhorn J; Sima D; Lindschau C; Turowski A; Schmidt H; Schneider W; Haller H; Luft FC
    Am J Med Sci; 1998 Jan; 315(1):17-23. PubMed ID: 9427570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond peripheral arteries in Buerger's disease: angiographic considerations in thromboangiitis obliterans.
    Hoppe B; Lu JT; Thistlewaite P; Yi ES; Mahmud E
    Catheter Cardiovasc Interv; 2002 Nov; 57(3):363-6. PubMed ID: 12410515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No ANCA in thromboangiitis obliterans (Bürger's disease).
    Schellong SM; Rautmann A; Gross WL; Alexander K
    Adv Exp Med Biol; 1993; 336():327-30. PubMed ID: 8296628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune mechanisms in thromboangiitis obliterans (Buerger's disease): the role of tobacco antigen and the major histocompatibility complex.
    Papa M; Bass A; Adar R; Halperin Z; Schneiderman J; Becker CG; Brautbar H; Mozes E
    Surgery; 1992 May; 111(5):527-31. PubMed ID: 1598672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of circulatory immune complexes in thromboangiitis obliterans (Buerger's disease).
    Gulati SM; Saha K; Kant L; Thusoo TK; Prakash A
    Angiology; 1984 May; 35(5):276-81. PubMed ID: 6426348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anticardiolipin antibodies in patients with Buerger's disease].
    Cnotliwy M; Gutowski P; Szumiłowicz H; Kucharska E; Jastrzebska M; Ostanek L
    Wiad Lek; 1999; 52(7-8):332-6. PubMed ID: 10540577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboangiitis obliterans (Buerger's disease).
    Klein-Weigel PF; Richter JG
    Vasa; 2014 Sep; 43(5):337-46. PubMed ID: 25147010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buerger's disease and anticardiolipin antibodies.
    Pereira de Godoy JM; Braile DM
    J Cardiovasc Med (Hagerstown); 2009 Oct; 10(10):792-4. PubMed ID: 19455050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endarteritis obliterans in the pathogenesis of Buerger's disease from the pathological and immunohistochemical points of view.
    Kobayashi M; Sugimoto M; Komori K
    Circ J; 2014; 78(12):2819-26. PubMed ID: 25298073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two female nonsmoker Buerger's disease cases with anticardiolipin autoantibodies and a poor prognosis.
    Heper G; Kose S; Akkoc O; Amasyali B; Kilic A
    Int Heart J; 2005 May; 46(3):563-9. PubMed ID: 16043952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating immune complexes in Buerger's disease. Endarteritis obliterans in young men.
    Roncon de Albuquerque R; Delgado L; Correia P; Torrinha JF; Serrão D; Braga A
    J Cardiovasc Surg (Torino); 1989; 30(5):821-5. PubMed ID: 2808505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G-protein coupled receptor auto-antibodies in thromboangiitis obliterans (Buerger's disease) and their removal by immunoadsorption.
    Klein-Weigel PF; Bimmler M; Hempel P; Schöpp S; Dreusicke S; Valerius J; Bohlen A; Boehnlein JM; Bestler D; Funk S; Elitok S
    Vasa; 2014 Sep; 43(5):347-52. PubMed ID: 25147011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thromboangiitis obliterans (Buerger's disease). Study of 41 cases].
    Fernández-Miranda C; Rubio R; Vicario JL; Arnaiz A; Fernández Sáez R; Mollejo M; Pulido F; del Palacio A; Lázaro T
    Med Clin (Barc); 1993 Sep; 101(9):321-6. PubMed ID: 8412397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological studies in thromboangitis obliterans (Buerger's disease).
    Gulati SM; Singh KS; Thusoo TK; Saha K
    J Surg Res; 1979 Nov; 27(5):287-93. PubMed ID: 390247
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of autoimmunity in thromboangiitis obliterans (Buerger's disease).
    Ketha SS; Cooper LT
    Ann N Y Acad Sci; 2013 May; 1285():15-25. PubMed ID: 23510296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.